This innovative programme is designed to develop future leaders in surgical oncology by combining cutting-edge scientific research with advanced surgical training. It offers a comprehensive and flexible doctoral curriculum for surgical residents, certified surgeons, and cancer-focused gastroenterologists and oncologists.

Artificial intelligence (AI) is a spectacular tool that has been in development for the last decades; its role in our lives is already pervasive and will inevitably grow; and, most importantly, we can, through regulation, avoid its abuses (such as fake news and the manipulation of human beings). Indeed, whatever the future of AI is to be, we have the power to choose – wisely – to use it for the common good.

We all have freckles and spots on our bodies of different shapes, sizes and textures. Most of these are perfectly safe and healthy, but some are not - knowing how to tell the difference could be life-saving. The CF Dermatology Unit provided this image and, with a little help from AI, let’s find out what we are looking at this week!

To familiarise health professionals with the latest artificial intelligence (AI) tools, so that they can apply them in their daily practice for the benefit of patients: this is the aim of the MEDICA AI conference, which will be held on July 16th at the Champalimaud Foundation (CF). The event is organised by the Digital Surgery Lab, a multidisciplinary team from the Breast Unit of the CF led by surgeon Pedro Gouveia.
 

A Fundação Champalimaud está à procura de Radiologistas para se juntarem à nossa equipa médica na Fundação Champalimaud. Se está interessado em imagiologia oncológica e investigação e empenhado em prestar cuidados de saúde de alta qualidade, envie a sua candidatura.

Public Lecture: Exploration of the Unknown in the Age of Science

By Ronald A. DePinho, MD, PhD (hc), DSc (hc) 
University of Texas MD Anderson Cancer Center, Houston, Texas

This public lecture will address the escalating medical, economic, and social challenges posed by an aging world population, highlighting how scientific discovery is illuminating new preventive and curative strategies to mitigate this burden.

This conference stands as a landmark event for the Botton-Champalimaud Pancreatic Cancer Centre in 2024 and will unite leading minds in translational science, oncology and surgery to tackle the complexities of pancreatic cancer.

The conference will serve as a pivotal platform for the exchange of groundbreaking insights, state-of-the-art surgical methodologies, and innovative therapeutic approaches that will ultimately enhance patient care and outcomes on a global scale.

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.

Rita Fior, leader of the Cancer Development and Innate Immune Evasion Group at the Champalimaud Foundation (CF), has been studying for several years the power of zebrafish “avatars”, or zAvatars, of cancer patients to help guide therapeutic decisions. The goal: to predict individual cancer treatment outcomes, thus enabling the selection of the best available chemotherapy treatment for each patient.

The images created during the daily scientific and medical endeavours at the Champalimaud Foundation can be as beautiful and compelling as any work of art. To the untrained eye, these images might also appear baffling, but, if you know what you’re looking at, they may just reveal information that can spark discoveries, contribute to the improvement of patient quality of life and maybe even alter our understanding of reality.